Abbott Laboratories News

The Emeryville company, which makes software for streaming video and video content management, said Monday it will use the funds to speed up product development and expand marketing.

Stocks expected to move actively in Wednesday's trading include Abbott Labs, ASML Holding, Asyst, Church & Dwight, CSX, R.R. Donnelley, eBay, Intel, Old Dominion Freight Line, Seagate and Time Warner.

Abbott Laboratories will lay off a "very small number" of employees in coming weeks as part of what a company spokesman termed a departmental restructuring.

Kelvin Lee used to visit the doctor as part of his daily routine an ot as a patient seeking help, but as a pharmaceutical sales representative for Abbott Laboratories.

Abbott Laboratories July 16, 2008, 09:00 AM ET Executives John B. Thomas - VP, IR Thomas C. Freyman - EVP, Finance and CFO Analysts Michael Weinstein - J.P. Morgan Lawrence Keusch - Goldman Sachs Bruce Nudell - ...

Abbott Laboratories results - MarketWatch Intraday data provided by Interactive Data Real Time Services , a division of Interactive Data Corp.

Guidance Analysts are looking for a profit of 79c on revenue of $7.23B. The consensus range is 76c to 79c for EPS, and revenue of $7.15B to $7.38B, according to First Call.

Abbott Laboratories, the fourth-biggest U.S. drugmaker, must face a trial on claims it deceived workers who joined its Hospira Inc.

Abbott Laboratories Inc. said July 2 that a stent designed, developed and manufactured by its Silicon Valley unit has been approved by the U.S. Food and Drug Administration.

Abbott India Ltd, the Indian arm of the US based multinational drug major Abbott Laboratories, has announced to buy back 7,97,500 shares of the company at a price of Rs 630 per Share.

Federal regulators are investigating whether a group of best-selling arthritis drugs made by Abbott Laboratories , Schering-Plough Corp.

A new generation of drug-coated stents - the small scaffoldlike devices that hold clogged arteries open - is now available for people with coronary artery disease.

Abbott Laboratories shares rose Wednesday evening after regulators approved the use of one of its medical devices, and Dell Inc.

Among the companies whose shares are expected to see active trade in Thursday's abbreviated session are Nvidia Corp., Abbott Laboratories, and AMR Corp.

GuruFocus Home >> Stock Ideas >> Recent Picks >> Abbott Laboratories ABT - Abbott Laboratories $81.8 Bil 11.74% 18.15 27.4% 4.61 18.59% 3.16 14.39% 2.72% 45% $2.92 1543.3 Mil Abbott Laboratories is a global ...

Federal regulators Wednesday approved Abbott Laboratories' drug-coated stent Xience V for sale in the United States, opening up a long-term -- and potentially very lucrative -- market for a product manufactured ...

Posted Jul 3rd 2008 1:10PM by Jon Ogg Filed under: Abbott Laboratories Today was a good end to a strange trading week, while many shares had light volume with today's half-day trading session.

Boston Scientific Corp. announced Wednesday that the U.S. Food and Drug Administration has approved the company's Promus drug-coated coronary stent.

Abbott Laboratories won U.S. approval for its Xience heart stent, a product analysts predict will lead a $4 billion-a-year market for the artery-opening devices.

A growing support group is joining 7-year-old Michaela Thomas in her battle against cancer.